Anders Kronborg

Chairman of the Board of Directors

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Apr 30, 2024 – Mar 10, 2026

Anders Kronborg reported 6 transactions between Apr 30, 2024 and Mar 10, 2026. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
471.7K SEK
4 purchases on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
6
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

4 insiders bought SynAct Pharma AB shares worth 316,466 SEK between Mar 3, 2026 and Mar 10, 2026

Cluster buying

4 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade. At least one price in this event could not be cross-checked against other trades in the same security, so read the total with extra care.

4 insiders bought SynAct Pharma AB shares worth 316,466 SEK between Mar 3, 2026 and Mar 10, 2026
Date Insider Transaction Shares Price Value Filing
Mar 3, 2026 Thomas Boesen SACQ Acquisition 2,700 17.90 SEK 48,330 SEK FI filing ↗
Mar 3, 2026 Thomas Boesen SACQ Acquisition 2,750 17.92 SEK 49,280 SEK FI filing ↗
Mar 5, 2026 Jeppe Øvli Øvlesen SACQ Acquisition 7,900 17.99 SEK 142,146 SEK FI filing ↗
Mar 5, 2026 Mads Liebach Bjerregaard SACQ Acquisition 1,500 17.92 SEK 26,880 SEK FI filing ↗
Mar 10, 2026 Anders Kronborg SACQ Acquisition 2,750 18.12 SEK 49,830 SEK FI filing ↗

Total of the rows above: 316,466 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

3 reporting parties bought SynAct Pharma AB shares worth 215,899 SEK between Dec 17, 2025 and Dec 19, 2025

Cluster buying

3 different reporting parties made 3 open-market purchases of this company’s shares within a short window. We call them reporting parties rather than insiders because we cannot confirm that every one of them is an individual: registers also list parent companies, funds and holding companies. Each row below is one reported trade.

3 reporting parties bought SynAct Pharma AB shares worth 215,899 SEK between Dec 17, 2025 and Dec 19, 2025
Date Insider Transaction Shares Price Value Filing
Dec 17, 2025 Quantass ApS SACQ Acquisition 3,529 20.24 SEK 71,429 SEK FI filing ↗
Dec 19, 2025 Anders Kronborg SACQ Acquisition 3,470 20.84 SEK 72,301 SEK FI filing ↗
Dec 19, 2025 Thomas Jonassen SACQ Acquisition 3,529 20.45 SEK 72,168 SEK FI filing ↗

Total of the rows above: 215,899 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

6 insiders bought SynAct Pharma AB shares worth 945,597 SEK between Jun 19, 2025 and Jun 25, 2025

Cluster buying

6 different insiders made 7 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

6 insiders bought SynAct Pharma AB shares worth 945,597 SEK between Jun 19, 2025 and Jun 25, 2025
Date Insider Transaction Shares Price Value Filing
Jun 19, 2025 Anders Kronborg SACQ Acquisition 6,150 16.19 SEK 99,556 SEK FI filing ↗
Jun 19, 2025 Thomas Boesen SACQ Acquisition 6,250 16.22 SEK 101,380 SEK FI filing ↗
Jun 19, 2025 Jeppe Oevlesen SACQ Acquisition 18,500 16.04 SEK 296,819 SEK FI filing ↗
Jun 23, 2025 Thomas Jonassen SACQ Acquisition 18,800 16.31 SEK 306,684 SEK FI filing ↗
Jun 23, 2025 Sten Sörensen SACQ Acquisition 3,048 16.41 SEK 50,021 SEK FI filing ↗
Jun 25, 2025 Jeppe Oevlesen SACQ Acquisition 2,757 17.55 SEK 48,388 SEK FI filing ↗
Jun 25, 2025 Björn Westberg SACQ Acquisition 2,440 17.52 SEK 42,749 SEK FI filing ↗

Total of the rows above: 945,597 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

3 insiders bought SynAct Pharma AB shares worth 399,993 SEK between Dec 30, 2024 and Jan 3, 2025

Cluster buying

3 different insiders made 3 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought SynAct Pharma AB shares worth 399,993 SEK between Dec 30, 2024 and Jan 3, 2025
Date Insider Transaction Shares Price Value Filing
Dec 30, 2024 Björn Westberg SACQ Acquisition 11,560 8.65 SEK 99,994 SEK FI filing ↗
Dec 30, 2024 Anders Kronborg SACQ Acquisition 28,902 8.65 SEK 250,002 SEK FI filing ↗
Jan 3, 2025 Sten Sörensen SACQ Acquisition 5,780 8.65 SEK 49,997 SEK FI filing ↗

Total of the rows above: 399,993 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 6 most recent rows are grouped into 6 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. SynAct Pharma AB SACQ Acquisition 2,750 shares 49.8K SEK at 18.12 SEK FI filing ↗
  2. SynAct Pharma AB SACQ Acquisition 3,470 shares 72.3K SEK at 20.84 SEK FI filing ↗
  3. SynAct Pharma AB SACQ Acquisition 6,150 shares 99.6K SEK at 16.19 SEK FI filing ↗
  4. SynAct Pharma AB SACQ Acquisition 28,902 shares 250.0K SEK at 8.65 SEK FI filing ↗
  5. SynAct Pharma AB SALL Allotmentnot a buy/sell decisionreported at zero 330,371 shares 0 SEK at 0.00 SEK FI filing ↗
  6. SynAct Pharma AB SSUB Subscriptionnot a buy/sell decision 34,883 shares 300.0K SEK at 8.60 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
SynAct Pharma AB SE0008241491 SynAct Pharma AB 76,155 FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Anders Kronborg reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.